ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Structurally Constrained Cyclic (Diacyloxyiodo)Arenes as an Enabling Platform for Hypervalent Iodine(III) Chemistry.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Gold Redox Catalysis Enabled by Cyclic Diacyl Peroxides for Homocoupling and Cross-Coupling of Terminal Alkynes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026Article
- Spatial Control Over Tether-Tunable Coordination on Palladium for Divergent Synthesis of Bicyclo[n.1.0]alkanes via Oxidative Cyclopropanation of Enynes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Structurally Constrained Cyclic (Diacyloxyiodo)Arenes as an Enabling Platform for Hypervalent Iodine(III) Chemistry.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Hypervalent iodine(III) chemistry has unlocked remarkable potential in synthetic and catalytic applications over the past decades, yet its development has been constrained by biased thermodynamics between iodine(I) and iodine(III) species, relying on unstable or environmentally unfriendly oxidants and complex electrocatalytic platforms. Here, structurally constrained cyclic (diacyloxyiodo)arenes are presented as a transformative platform to resolve the reactivity/selectivity-generality paradox, enabling one-pot synthesis of diverse hypervalent iodine(III) reagents. The synthetic utility and sustainability of the in situ controlled-release approach are demonstrated through catalytic reactions, asymmetric variations, and biocompatibility studies, including peptide modifications. Central to this success is the discovery of cyclic (diacyloxyiodo)arenes-a previously unexplored chemical entity. DFT calculations reveal that spatial dianion control via intramolecular secondary bonding enhances reactivity and selectivity while delivering superior outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.